Latest Posts
About This Stock
More About This Stock
Read
Read
Who Are The Next Acquisition Targets In Dermatology?

Article By:
Ari Zoldan
Wednesday, March 22, 2017 8:25 AM EDT
Specialty pharmaceuticals is a highly dynamic sector with robust stock valuations and an active mergers & acquisition market. One of the most attractive areas for investment is dermatology.
Foamix Announces Positive Phase 2 Results For FDX104 Treatment

Article By:
Terry Chrisomalis
Thursday, December 3, 2015 11:45 AM EDT
Today Foamix announced positive phase 2 results for its FDX104 foam treatment.